Led multiple digital health companies during last twenty years. Held executive positions with publicly traded companies (GE, Roche, Hillrom, Stereotaxis) and led two venture-backed companies as CEO. Most recently President & CCO of diagnostic company with autonomous AI technology that was FDA-cleared, Medicare-reimbursed, supported by a new Category 1 CPT code, and adopted around the world.
Prof. Charalambos Antoniades
Co-founder & Chief Scientific Officer
MD PhD FESC Pioneered the research on the relationship between adipose tissue and the cardiovascular system, with specific interest in non-invasive imaging of inflammation. This knowledge has been applied in a variety of diseases, ranging from cardiovascular disease to COVID-19. Deputy Head of the Division of Cardiovascular Medicine at the University of Oxford, and Chair of the British Atherosclerosis Society.
Prof. Keith Channon
Co-founder & Chief Medical Officer
Clinical interventional cardiologist and highly experienced research leader in cardiometabolic disease and risk. Professor at the University of Oxford, with expertise in healthcare innovations in the NHS through NIHR and Director of Academic Health Science Centre.
Prof. Stefan Neubauer
Co-founder & Chief Translational Officer
MD FRCP FACC FMedSci FSCMR Devoted his work to the development and application of novel imaging techniques in MRI and spectroscopy, and most recently in coronary CT. Head of the Division of Cardiovascular Medicine and Director of the Oxford Centre for Clinical Magnetic Resonance Research (OCMR) at the University of Oxford and Past President of the Society for Cardiovascular Magnetic Resonance (SCMR).
Dr. Cheerag Shirodaria
Co-founder and Chief Development Officer
MBBS MD MBA FRCP Has been involved in cardiovascular research for more than 25 years. Was General Manager for Medical Devices & Diagnostics and Cardiovascular Therapeutic Area Head at Covance. Is an Honorary Consultant Cardiologist at Oxford University Hospitals NHS Foundation Trust.
Pete Tomlins, Ph.D
Head of Innovation & Research
PhD, CPhys Chartered Physicist with over 20 years’ research experience in National Labs, academia, and university spin-out. Pete has led technology research programmes, run a data science consultancy, and built prototype medical imaging systems from the ground up. He is passionate about improving health outcomes with data and AI.
Matt Kelly, Ph.D
Head of IP & Clinical Strategy
Ph.D with a passion for delivering innovative technology to improve clinical outcomes. Experienced leader with over 20 years’ experience across the full product lifecycle, translating inspiration into regulatory-cleared medical devices and generating the clinical evidence and IP protection necessary for commercial success.
Head of Commercialization, Europe
With over 15 years of dedicated experience in the medical devices industry, specialising in the field of cardiology, Rebecca has been at the forefront of cardiovascular technology innovation and has developed her expertise within organisations such as Abbott, St. Jude, and Bard. Her journey led her to a senior role within a dynamic start-up, where her efforts resulted in achieving NHS and European acceptance for innovative healthcare solutions.
PhD Corporate and commercial solicitor with extensive experience advising emerging and established companies on commercial contracts, protection of intellectual property rights, regulatory and corporate governance matters, strategic relationships and financings
Head of Quality and Regulatory
Over 20 years experience working with medical devices at large multinational companies as well as startup and SMEs. Responsible for regulatory compliance and quality management, has set up a combined management system compliant to ISO 9001, 13485 and 27001 requirements.
Head of Image Analysis
BSc (Hons) Diagnostic Radiography. In excess of 10 years of experience as a Radiographer across multiple imaging modalities including PET-CT, Nuclear Medicine, and CT. Substantial experience in managing and co-ordinating multiple imaging trials at the cutting edge of healthcare innovations at the University of Oxford and Oxford University Hospitals NHS Foundation Trust.
Project & Operations Manager
BE, MBA with over 17 years of experience in Project Management, Operation Management and Information Technology. Has experience in the healthcare sector on embedded technology, medical imaging and software only devices at start-ups as well as multinational organisations.
Registered in England and Wales under company number 11429590
CaRi-Heart® is limited to investigational use in the United States.
All contents of this website are copyright 2018 - 2021 Caristo Diagnostics Ltd. All rights reserved. No content may be copied or reproduced without the express permission of Caristo Diagnostics Ltd.
All copyright, trade-marks, design rights, database rights, patents and other intellectual property rights (registered and unregistered) in and on this website are owned by Caristo Diagnostics Ltd. and/or certain third parties.